Gilead Sciences (GILD) announced that it has priced senior unsecured notes totaling $3B in a public offering.

This includes $500M of 4.250% senior notes maturing in 2028, $1B of 4.400% senior notes maturing in 2029, $1B of 4.600% senior notes maturing in 2031, and $500M of 4.900% senior notes